Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
Kekre N, Kim HT, Hofer J, Ho VT, Koreth J, Armand P, Nikiforow S, Gooptu M, Romee R, Alyea EP, Nageshwar P, Glotzbecker B, El-Jawahri A, DeFilipp Z, Soiffer RJ, Antin JH, Chen YB, Cutler C.
Kekre N, et al. Among authors: antin jh.
Bone Marrow Transplant. 2021 May;56(5):1217. doi: 10.1038/s41409-020-01083-y.
Bone Marrow Transplant. 2021.
PMID: 33041331
No abstract available.